Use of a New Ocular Insert versus Conventional Mydriasis in Cataract Surgery
Autor: | Pilar Calvo, Oscar Ruiz-Moreno, A. Pérez-Iñigo, Jesús Leciñena, C. Torrón |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Male
Mydriatics Article Subject genetic structures medicine.medical_treatment lcsh:Medicine Blood Pressure Cataract Extraction General Biochemistry Genetics and Molecular Biology Pupil Heart Rate Mydriasis Pupillary response Humans Medicine Phenylephrine Aged General Immunology and Microbiology business.industry Tropicamide lcsh:R General Medicine Cataract surgery Phenylephrine Hydrochloride Cyclopentolate eye diseases Anesthesia Clinical Study Female sense organs medicine.symptom business medicine.drug |
Zdroj: | BioMed Research International, Vol 2013 (2013) Zaguán. Repositorio Digital de la Universidad de Zaragoza instname BioMed Research International |
ISSN: | 2314-6141 2314-6133 |
Popis: | Background. To compare the efficacy and safety of a new ocular insert versus conventional mydriasis in cataract surgery.Methods. We selected 70 patients undergoing cataract surgery. Thirty five patients (Group 1) received instillation of mydriatic drops (tropicamide 1%, phenylephrine 10%, and cyclopentolate 1%) prior to surgery, and 35 patients (Group 2) had a Mydriasert insert (Théa Pharma) (0.28 mg of tropicamide and 5.4 mg of phenylephrine hydrochloride) placed in the inferior fornix. Pupil size before and after surgery, blood pressure, and heart rate were measured.Results. Before surgery, pupil diameter was mm in Group 1 and in Group 2 (). Twenty four hours after surgery, pupil diameter was mm in Group 1 and in Group 2 (). There were no statistically significant differences in blood pressure or heart rate between groups.Conclusions. The effect of the Mydriasert insert was similar to conventional mydriatic agents. Pupil size was restored to normal faster when using the Mydriasert insert compared with conventional mydriatic agents for pupil dilation. |
Databáze: | OpenAIRE |
Externí odkaz: |